StockMarketWire.com - DeepMatter said it had teamed up with AstraZeneca to improve the productivity of rolling out new drugs using digital technologies.

Scientists from the two organisations would work together to improve the productivity of synthesising single compounds and compound libraries based on data harvested from DeepMatter's so-called DigitalGlassware technology. DigitalGlassware allowed users to capture and analyse information about chemical reactions.

Story provided by StockMarketWire.com